Across TCGA pan-cancer cohorts, VN1R35P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of VN1R35P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where VN1R35P RNA is repressed in tumor relative to normal tissue. In most cancer types VN1R35P is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

THCA and COAD are the cancer types where VN1R35P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in VN1R35P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	III,IV	−0.155	<.001	10	view →
COAD	Female	All	+0.094	.018	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: VN1R35P RNA expression & survival · all VN1R35P data types